Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026
recent articles
Big news this morning with acquisition of Definiens by MedImmune, strengthening MedImmune's focus on the discovery of novel predictive biomarkers in immune-oncology. Good news for patients and their providers. Tuesday, 4 November 2014 -...
Attended Pathology Visions 2014 a few weeks ago in San Francisco, CA. Having missed the meeting the past couple of years and perhaps not being able to speak first hand about the quality of the content of those meetings (2012 was upended by a...
Visit Definiens at booth #213 at the SITC Annual Meeting to learn how Definiens’ image analysis solutions are being used in the SITC-led effort to validate The Immunoscore™ as a prognostic biomarker for colon cancer. At the conference we...
Your AP Lab’s Information System Commute: When is ‘Taking the Bus’ More Flexible than ‘Driving Your Car’? The Dark Report is pleased to offer this FREE White Paper providing you with a detailed discussion on the considerations...
Announcing the NEW Mantra™ workstation with inForm® advanced image analysis Software from PerkinElmer, to quantify, phenotype, and detect spatial relationships among immune cells in situ in FFPE tissue. It’s a semi-automated imaging...
Thursday 30th October 2014 | 11:00 AM - 12:00 PM CST / 4:00 PM - 5:00 PM BST Register here PathXL’s award winning product, TissueMark®, assists the pathologist with automated tumor detection and analysis for molecular pathology...
